ﺑﺎﺯﮔﺸﺖ ﺑﻪ ﺻﻔﺤﻪ ﻗﺒﻠﯽ
خرید پکیج
تعداد آیتم قابل مشاهده باقیمانده : 3 مورد
نسخه الکترونیک
medimedia.ir

Microbiology, epidemiology, and pathogenesis of Legionella infection

Microbiology, epidemiology, and pathogenesis of Legionella infection
Literature review current through: Jan 2024.
This topic last updated: Feb 22, 2022.

INTRODUCTION — Legionella bacteria are aerobic, gram-negative, intracellular pathogens that are important causes of community-acquired and nosocomial pneumonia. Legionella infections can be acquired sporadically or during outbreaks. Legionella bacteria are typically transmitted via inhalation aerosols from contaminated water or soil.

The microbiology, epidemiology, and pathogenesis of Legionella infections will be reviewed here. Clinical manifestations, diagnosis, and treatment of this entity are discussed separately. (See "Clinical manifestations and diagnosis of Legionella infection" and "Treatment and prevention of Legionella infection".)

DEFINITIONS — The term legionellosis refers to any clinical syndrome associated with Legionella infection. The two most common syndromes associated with Legionella infection are:

Legionnaires' disease, which refers to pneumonia caused by Legionella spp

Pontiac fever, which is an acute, self-limited febrile illness that is typically acquired during outbreaks

Extrapulmonary legionellosis refers to infection outside the lung (eg, cellulitis, endocarditis, peritonitis) and is rare but reported. (See "Clinical manifestations and diagnosis of Legionella infection".)

MICROBIOLOGY

Pathogen — Legionella bacteria are aerobic, nutritionally fastidious, gram-negative bacilli and facultative intracellular pathogens [1].

The bacterial family Legionellaceae consists of >60 species and >70 serogroups [2,3]. Legionella pneumophila, the most common cause of human disease, is divided into >15 serogroups [3,4]. L. pneumophila serogroup 1 is the most prevalent, although nearly all serogroups have been reported to cause human disease [4,5].

At least 26 other Legionella species are pathogenic in humans. L. longbeachae is the second most common cause of human disease [4,6]. L. micdadei, L. bozemanii, L. feeleii, L. anisa, and L. dumoffii are also established human pathogens [3].

Environmental reservoir — Legionellae are environmental organisms found in water and soil [1]. Environmental reservoirs vary among species.

L. pneumophila and most other Legionella species mainly reside in bodies of water, such as lakes, streams, and artificial water reservoirs. Within water, Legionellae can live planktonically, in biofilms, or as intracellular parasites within protozoa (eg, free-living amoeba and ciliates) [7]. Replication within protozoa protects the organism from temperature shifts, pH changes, and nutrient-poor environments. Additional factors that promote growth in water include warm temperatures (25 to 42°C), stagnation, and sedimentation.

By contrast, L. longbeachae is genetically adapted to invade plant material and primarily resides in soil and compost [8-11]. While Legionella species have preferred growth environments, their habitats are not discrete. L. pneumophila and other Legionella species can occasionally be found in soil and compost [12]. Conversely, L. longbeachae has been found in water sources [13,14].

Transmission — Legionella bacteria are typically transmitted to humans via inhalation of aerosols derived from water or soil [8,15]. The infectious dose for humans has not been precisely quantified but is likely high, requiring >1000 organisms to cause infection [1,16].

Contamination of water sources with concentrations of Legionella high enough to cause human infection can occur when changes in water flow or pressure disrupt biofilms, releasing large amounts of bacteria into the surrounding water [1]. Legionella's ability to grow intracellularly within free-living amoeba may also facilitate transmission from either water or soil [1,17,18]. A single infected amoebal cyst may contain thousands of Legionella bacteria and, if aerosolized, could easily deliver an infectious dose.

Laboratory and person-to-person transmission generally do not occur, likely due to the high infectious dose. However, a single case of possible person-to-person transmission has been reported [19].

The incubation period ranges from 2 to 10 days (median 4 to 6 days) for Legionnaires' disease and from approximately 4 hours to 3 days (median 32 to 36 hours) for Pontiac fever [1].

EPIDEMIOLOGY

Incidence and prevalence

Legionnaires' disease — The reported incidence of Legionnaires' disease is approximately 1.4 to 1.8 cases per 100,000 persons in the United States, Europe, and Australia [20-22]. Within these regions, local rates range from approximately 0.4 to 5.0 cases per 100,000 persons. The highest reported incidence (5.4 cases per 100,000 persons) is in New Zealand, where L. longbeachae causes the majority of disease [23,24]. Across these regions, reported incidences are rising [20,21,25,26]. However, this rise in incidence may reflect increased awareness, improved diagnostic tests, and/or changes in reporting standards rather than a true rise in incidence.

Legionnaires' disease may be community acquired or acquired in health care facilities.

Community-acquired pneumonia – Legionnaires' disease accounts for approximately 1 to 10 percent of cases of community-acquired pneumonia (CAP) [27-32]. CAP caused by legionellae is most often diagnosed in hospitalized patients and can be severe. Up to 44 percent of patients have been reported to require intensive care unit admission, and the associated mortality is approximately 1 to 10 percent [20,33,34].

Nosocomial pneumonia – The prevalence of Legionnaires' disease in patients with nosocomial pneumonia is linked to presence and concentration of legionellae in the facility's water supply [35,36]. In the United States in 2015, approximately 20 percent of cases of Legionnaires' disease was acquired in hospitals or long-term care facilities [37].

Pontiac fever — The incidence of Pontiac fever is not well established because the syndrome is typically nonspecific and self-limited. However, outbreak investigations suggest that Pontiac fever may be more common than Legionnaires' disease during outbreaks [38,39].

Outbreaks — Legionella species cause both sporadic and epidemic infections. While the great majority of cases are sporadic, outbreaks are common.

Legionella bacteria were first identified as a result of the investigation of an outbreak of severe pneumonia among attendees at an American Legion convention in 1976 [40-42]. The initial outbreak involved 182 persons and was linked to contamination of the air conditioning system at the hotel where the convention was held.

Subsequently, Legionella has been identified as a common cause of waterborne disease outbreaks. During 2015, there were 54 reported Legionnaires' disease outbreaks in Europe alone, involving 559 cases from 11 countries [21]. While the largest of these outbreaks involved 304 persons, most affected <10 persons. Large outbreaks are often associated with contaminated industrial cooling towers or water systems that supply communities or facilities such as hospitals, hotels, cruise ships, or apartment buildings [43-49].

As examples, contaminated cooling towers were responsible for an outbreak at the Melbourne Aquarium that involved 125 visitors [47]. Seventy-six percent of patients required hospitalization, and the case-fatality rate was 3 percent. In an outbreak at a Dutch flower show, 188 visitors became ill after exposure to a contaminated whirlpool spa in the exhibition hall [50]. However, contamination of any water source can also lead to infection. (See 'Environmental exposures' below.)

L. pneumophila is by far the predominant species associated with outbreaks.

Geographic variation — Globally, L. pneumophila is the most commonly reported cause of Legionnaires' disease, causing over 90 percent of community-acquired cases [4]. Within L. pneumophila species, serogroup 1 predominates, causing approximately 85 percent of cases overall.

L. longbeachae is the second most commonly reported cause of Legionnaires' disease [6]. Although L. longbeachae accounts for approximately 4 percent of reported cases overall, its prevalence appears to be significantly higher in Australia and New Zealand, where it is reported to cause >50 percent of cases [24].

It is unclear how much of the global predominance of L. pneumophila is due to the widespread use of the urinary antigen test as the sole diagnostic, as this test only detects L. pneumophila serogroup 1.

Seasonality — Legionnaires' disease caused by L. pneumophila is possibly more common in late summer and early autumn [21,51,52], whereas that caused by L. longbeachae peaks in spring and early summer [33]. It is thought that these patterns reflect warmer, wetter weather and gardening activity, respectively [33,53].

Risk factors — Although Legionella bacteria are widespread in the environment, human infection is relatively rare. Even during large outbreaks, only a minority of persons in affected areas develop disease.

Host risk factors — Older age is strongly associated with Legionnaires' disease. In most cohort studies, >75 percent of patients with Legionnaires' disease are >50 years old [51,54,55]. Pediatric Legionnaires' disease does occur but is rare [56].

Immunocompromise, particularly impaired cellular immunity, has also been identified as a risk factor for Legionella infection. Acquired immunodeficiency syndrome (AIDS), hematologic malignancies, and diabetes mellitus have each been shown to be independent risk factors Legionnaires' disease in a large case-control study [51]. Solid organ transplantation, tumor necrosis factor-alpha inhibitors, and anti-CD52 agents have also been reported to increase the risk of infection [57-59].

Other commonly described risk factors include smoking (current or past), chronic respiratory disease, cardiovascular disease, and end-stage kidney disease [8,47,51,54]. Male sex and alcohol use have also been associated with increased risk of infection [60].

Environmental exposures — Most Legionella infections are associated with exposure to contaminated manmade water reservoirs. Reported sources of infection are diverse and include showers [61], pools [62], hot tubs [63], aquariums [47], fountains [64], birthing pools [65,66], drinking water systems [15,55], air conditioning systems and cooling towers [67,68], and other water collection systems [69,70]. Natural water systems, such as rivers and streams, are less common sources of infection [71].

Soil, potting mix, and compost exposure is also a risk factor for Legionella infection, particularly for L. longbeachae [8,72]. Gardening and specifically not washing one's hands after gardening are associated with an increased likelihood of infection with L. longbeachae [8,72].

PATHOGENESIS — The pathogenesis of L. pneumophila has been most comprehensively studied for Legionnaires' disease caused by L. pneumophila. Relatively little is known about the pathogenesis of Pontiac fever or Legionnaires' disease caused by non-pneumophila Legionella species.

Legionnaires' disease

L. pneumophila infection — L. pneumophila typically reaches the lung via inhalation and, less commonly, via microaspiration [73-75]. Within the alveoli, the bacteria attaches to alveolar macrophages and epithelial cells using flagella, pili, and outer membrane porins [76-81]. Phagocytosis is mediated by human complement component C3 and macrophage infectivity potentiator protein, a virulence factor expressed on L. pneumophila's cell surface.

Following phagocytosis, L. pneumophila uses a Dot/Icm type IV secretion system to translocate hundreds of effector proteins into the phagocytic vacuole [82-86]. These effector proteins inhibit phagosome-lysosome fusion, thereby allowing L. pneumophila to survive within the host cell. Effector proteins also recruit vesicles from the host cell's endoplasmic reticulum, which transform the phagocytic vacuole into an organelle that is competent for intracellular bacterial replication.

As L. pneumophila replicates, the vacuole expands to fill the cell. Upon exhaustion of host cell nutrients, the bacteria enter a stationary growth phase and develop flagella [87]. The flagella trigger caspase-1, which induces apoptosis, and progeny bacteria exit the cell, initiating a new amplification cycle [88]. While multiple other virulence factors and immune evasive mechanisms have been described for L. pneumophila, their role in pathogenesis is not clearly established. These include heat-shock protein Hsp60, which enhances epithelial cell invasion [89]; a lipopolysaccharide containing endotoxic activity; and the rcp gene, which appears to encode a lipid A-modifying enzyme, confers resistance to cationic peptides, and promotes macrophage and lung infection [90]. L. pneumophila also secretes a variety of proteins, degradative enzymes, and toxins primarily via a type II secretion system [85,91-96]. Additional immune-evasive mechanisms include the bacteria's ability to resist complement and cationic peptides in the extracellular space and ability to withstand free radical assault [80,81,90].

Infection with other Legionella species — Like L. pneumophila, most other Legionella species are transmitted via aerosol inhalation, invade alveolar macrophages, and replicate intracellularly, usually relying on a Dot/Icm type IV secretion [97-100]. However, specific virulence factors and effector proteins vary among species [82,100-103].

As an example, L. longbeachae is encapsulated and lacks flagella. The genome size is approximately 40 percent larger than L. pneumophila. Some of the added genetic sequences are believed to encode effector proteins derived from soil- and plant-dwelling microorganisms, which may enhance L. longbeachae pathogenicity [11,99,104]. In vitro and animal models also suggest that L. longbeachae infection might be more virulent than L. pneumophila infection [105]. In mice, infection with L. longbeachae is immunologically silent and causes lethal acute respiratory failure. By contrast, L. pneumophila infection is typically self-limited.

Host immune response — Th1 cell-mediated immunity is the primary means of immune control of Legionella infections. Macrophage activation, triggered by the innate immune system, also plays an important role in clearing infection [106-110]. The cytokines produced by infected alveolar macrophages are essential for the recruitment of neutrophils and for stimulating interferon-gamma production by natural killer cells, which are both needed for sterilization in the lung [109,111]. Although Legionella-specific antibodies develop during the course of infection, the humoral immune response does not appear to be critical for host defense.

Pontiac fever — The pathogenesis of Pontiac fever is not well characterized. The syndrome can be caused by most Legionella spp and is acquired by inhalation of the organism from the environment. Because the incubation period is short (four to six hours) and recovery is typically rapid, Pontiac fever is hypothesized to be a toxin-mediated illness.

SUMMARY

MicrobiologyLegionella bacteria are aerobic, gram-negative, intracellular pathogens that are commonly found in water and soil. Human infection is typically acquired through inhalation of aerosols from these substances. (See 'Microbiology' above.)

Common serotypesLegionella pneumophila serotype 1 is the most commonly reported cause of human Legionella infections worldwide. Legionella longbeachae is the second most common cause of human Legionella infections and is predominantly reported in Australia and New Zealand. (See 'Incidence and prevalence' above.)

Sporadic and epidemic infections − Most Legionella infections are sporadic; however, epidemics can occur and are often associated with exposure to contaminated communal water supplies in large facilities such as hospitals, hotels, or apartment buildings. (See 'Outbreaks' above and 'Environmental exposures' above.)

Clinical manifestations − The two major clinical syndromes association with Legionella infections are Legionnaires' disease (pneumonia) and Pontiac fever, an acute, nonspecific, self-limited febrile illness. (See 'Definitions' above and "Clinical manifestations and diagnosis of Legionella infection".)

Prevalence and age associationLegionella spp are estimated to cause about 2 to 10 percent of cases of community-acquired pneumonia, with over 75 percent of cases occurring in adults >50 years old. (See 'Incidence and prevalence' above and 'Risk factors' above.)

Risk factors − In addition to older age, risk factors for Legionnaires' disease include smoking, chronic respiratory disease, diabetes mellitus, and other immunocompromising conditions. (See 'Host risk factors' above.)

Pathogenesis of Legionnaires’ disease − The pathogenesis of Legionnaires' disease is complex but involves invasion of alveolar macrophages and epithelial cells, intracellular replication, and apoptosis of infected cells. Cell-mediated immunity is the primary means of immune control. (See 'Pathogenesis' above.)

Pathogenesis of Pontiac fever − Because of the self-limited and nonspecific nature of Pontiac fever, the epidemiology and pathogenesis of this disease have not been well characterized. (See 'Pontiac fever' above and 'Pathogenesis' above.)

ACKNOWLEDGMENTS — The UpToDate editorial staff acknowledges Victor Yu, MD, Janet Stout, PhD, Nieves Sopena Galindo, MD, and Patricia Priest, MBChB, DPhil, who contributed to earlier versions of this topic review.

  1. Edelstein PH and Roy CR. Legionnaires' Disease and Pontiac Fever. In: Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases, 8, Bennet JE, Dolin R and Blaser MJ (Eds), Elsevier, Pennsylvania 2015.
  2. LPSN bacterio.net. Genus Legionella. http://www.bacterio.net/legionella.html#r (Accessed on December 13, 2017).
  3. National Center for Biotechnology Information Taxonomy Browser. https://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?mode=Undef&id=445&lvl=3&lin=f&keep=1&srchmode=1&unlock (Accessed on February 01, 2018).
  4. Yu VL, Plouffe JF, Pastoris MC, et al. Distribution of Legionella species and serogroups isolated by culture in patients with sporadic community-acquired legionellosis: an international collaborative survey. J Infect Dis 2002; 186:127.
  5. Zhang Q, Zhou H, Chen R, et al. Legionnaires' disease caused by Legionella pneumophila serogroups 5 and 10, China. Emerg Infect Dis 2014; 20:1242.
  6. Chambers ST, Slow S, Scott-Thomas A, Murdoch DR. Legionellosis Caused by Non-Legionella pneumophila Species, with a Focus on Legionella longbeachae. Microorganisms 2021; 9.
  7. Eisenreich W, Heuner K. The life stage-specific pathometabolism of Legionella pneumophila. FEBS Lett 2016; 590:3868.
  8. Kenagy E, Priest PC, Cameron CM, et al. Risk Factors for Legionella longbeachae Legionnaires' Disease, New Zealand. Emerg Infect Dis 2017; 23:1148.
  9. Currie SL, Beattie TK. Compost and Legionella longbeachae: an emerging infection? Perspect Public Health 2015; 135:309.
  10. Whiley H, Bentham R. Legionella longbeachae and legionellosis. Emerg Infect Dis 2011; 17:579.
  11. Cazalet C, Gomez-Valero L, Rusniok C, et al. Analysis of the Legionella longbeachae genome and transcriptome uncovers unique strategies to cause Legionnaires' disease. PLoS Genet 2010; 6:e1000851.
  12. van Heijnsbergen E, van Deursen A, Bouwknegt M, et al. Presence and Persistence of Viable, Clinically Relevant Legionella pneumophila Bacteria in Garden Soil in the Netherlands. Appl Environ Microbiol 2016; 82:5125.
  13. Thornley CN, Harte DJ, Weir RP, et al. Legionella longbeachae detected in an industrial cooling tower linked to a legionellosis outbreak, New Zealand, 2015; possible waterborne transmission? Epidemiol Infect 2017; 145:2382.
  14. Potočnjak M, MagdaleniĆ Z, Dijan M, et al. Environmental factors affecting the survival of soil dwelling Legionella longbeachae in water. Ann Agric Environ Med 2016; 23:452.
  15. Benedict KM, Reses H, Vigar M, et al. Surveillance for Waterborne Disease Outbreaks Associated with Drinking Water - United States, 2013-2014. MMWR Morb Mortal Wkly Rep 2017; 66:1216.
  16. Berendt RF, Young HW, Allen RG, Knutsen GL. Dose-response of guinea pigs experimentally infected with aerosols of Legionella pneumophila. J Infect Dis 1980; 141:186.
  17. Byrne B, Swanson MS. Expression of Legionella pneumophila virulence traits in response to growth conditions. Infect Immun 1998; 66:3029.
  18. Conza L, Pagani SC, Gaia V. Presence of Legionella and free-living Amoebae in composts and bioaerosols from composting facilities. PLoS One 2013; 8:e68244.
  19. Correia AM, Ferreira JS, Borges V, et al. Probable Person-to-Person Transmission of Legionnaires' Disease. N Engl J Med 2016; 374:497.
  20. Dooling KL, Toews KA, Hicks LA, et al. Active Bacterial Core Surveillance for Legionellosis - United States, 2011-2013. MMWR Morb Mortal Wkly Rep 2015; 64:1190.
  21. European Center for Disease Prevention and Control. Legionnaires’ disease - Annual Epidemiological Report for 2015. ECDC; Stockholm, 2015.
  22. NNDSS Annual Report Working Group. Australia's notifiable disease status, 2014: Annual report of the National Notifiable Diseases Surveillance System. Commun Dis Intell Q Rep 2016; 40:E48.
  23. Phin N, Parry-Ford F, Harrison T, et al. Epidemiology and clinical management of Legionnaires' disease. Lancet Infect Dis 2014; 14:1011.
  24. Priest PC, Slow S, Chambers ST, et al. The burden of Legionnaires' disease in New Zealand (LegiNZ): a national surveillance study. Lancet Infect Dis 2019; 19:770.
  25. The Institute of Environmental Science and Research Ltd. Notifiable Diseases in New Zealand: Annual Report 2016. 2017, Porirua.
  26. Beauté J, The European Legionnaires' Disease Surveillance Network. Legionnaires' disease in Europe, 2011 to 2015. Euro Surveill 2017; 22.
  27. Marchello C, Dale AP, Thai TN, et al. Prevalence of Atypical Pathogens in Patients With Cough and Community-Acquired Pneumonia: A Meta-Analysis. Ann Fam Med 2016; 14:552.
  28. Murdoch DR, Chambers ST. Atypical pneumonia--time to breathe new life into a useful term? Lancet Infect Dis 2009; 9:512.
  29. Musher DM, Abers MS, Bartlett JG. Evolving Understanding of the Causes of Pneumonia in Adults, With Special Attention to the Role of Pneumococcus. Clin Infect Dis 2017; 65:1736.
  30. von Baum H, Ewig S, Marre R, et al. Community-acquired Legionella pneumonia: new insights from the German competence network for community acquired pneumonia. Clin Infect Dis 2008; 46:1356.
  31. Jain S, Self WH, Wunderink RG, et al. Community-Acquired Pneumonia Requiring Hospitalization among U.S. Adults. N Engl J Med 2015; 373:415.
  32. Neill AM, Martin IR, Weir R, et al. Community acquired pneumonia: aetiology and usefulness of severity criteria on admission. Thorax 1996; 51:1010.
  33. Isenman HL, Chambers ST, Pithie AD, et al. Legionnaires' disease caused by Legionella longbeachae: Clinical features and outcomes of 107 cases from an endemic area. Respirology 2016; 21:1292.
  34. Viasus D, Di Yacovo S, Garcia-Vidal C, et al. Community-acquired Legionella pneumophila pneumonia: a single-center experience with 214 hospitalized sporadic cases over 15 years. Medicine (Baltimore) 2013; 92:51.
  35. Stout J, Yu VL, Vickers RM, et al. Ubiquitousness of Legionella pneumophila in the water supply of a hospital with endemic Legionnaires' disease. N Engl J Med 1982; 306:466.
  36. Kanamori H, Weber DJ, Rutala WA. Healthcare Outbreaks Associated With a Water Reservoir and Infection Prevention Strategies. Clin Infect Dis 2016; 62:1423.
  37. Soda EA, Barskey AE, Shah PP, et al. Vital Signs: Health Care-Associated Legionnaires' Disease Surveillance Data from 20 States and a Large Metropolitan Area - United States, 2015. MMWR Morb Mortal Wkly Rep 2017; 66:584.
  38. Ambrose J, Hampton LM, Fleming-Dutra KE, et al. Large outbreak of Legionnaires' disease and Pontiac fever at a military base. Epidemiol Infect 2014; 142:2336.
  39. Burnsed LJ, Hicks LA, Smithee LM, et al. A large, travel-associated outbreak of legionellosis among hotel guests: utility of the urine antigen assay in confirming Pontiac fever. Clin Infect Dis 2007; 44:222.
  40. Fraser DW, Tsai TR, Orenstein W, et al. Legionnaires' disease: description of an epidemic of pneumonia. N Engl J Med 1977; 297:1189.
  41. Honigsbaum M. Legionnaires' disease: revisiting the puzzle of the century. Lancet 2016; 388:456.
  42. McDade JE, Shepard CC, Fraser DW, et al. Legionnaires' disease: isolation of a bacterium and demonstration of its role in other respiratory disease. N Engl J Med 1977; 297:1197.
  43. Rhoads WJ, Garner E, Ji P, et al. Distribution System Operational Deficiencies Coincide with Reported Legionnaires' Disease Clusters in Flint, Michigan. Environ Sci Technol 2017; 51:11986.
  44. Fitzhenry R, Weiss D, Cimini D, et al. Legionnaires' Disease Outbreaks and Cooling Towers, New York City, New York, USA. Emerg Infect Dis 2017; 23.
  45. Yackley JK, Sweat D, Fill MA, et al. Notes from the Field: Legionellosis Outbreak Associated with a Hotel Aquatics Facility - Tennessee, 2017. MMWR Morb Mortal Wkly Rep 2018; 67:77.
  46. Chaudhry R, Sreenath K, Arvind V, et al. Legionella pneumophila Serogroup 1 in the Water Facilities of a Tertiary Healthcare Center, India. Emerg Infect Dis 2017; 23:1924.
  47. Greig JE, Carnie JA, Tallis GF, et al. An outbreak of Legionnaires' disease at the Melbourne Aquarium, April 2000: investigation and case-control studies. Med J Aust 2004; 180:566.
  48. Mouchtouri VA, Rudge JW. Legionnaires' Disease in Hotels and Passenger Ships: A Systematic Review of Evidence, Sources, and Contributing Factors. J Travel Med 2015; 22:325.
  49. Inglis TJJ, Spittle C, Carmichael H, et al. Legionnaires' Disease Outbreak on a Merchant Vessel, Indian Ocean, Australia, 2015. Emerg Infect Dis 2018; 24:1345.
  50. Den Boer JW, Yzerman EP, Schellekens J, et al. A large outbreak of Legionnaires' disease at a flower show, the Netherlands, 1999. Emerg Infect Dis 2002; 8:37.
  51. Marston BJ, Lipman HB, Breiman RF. Surveillance for Legionnaires' disease. Risk factors for morbidity and mortality. Arch Intern Med 1994; 154:2417.
  52. Rucinski SL, Murphy MP, Kies KD, et al. Eight Years of Clinical Legionella PCR Testing Illustrates a Seasonal Pattern. J Infect Dis 2018; 218:669.
  53. Amodeo MR, Murdoch DR, Pithie AD. Legionnaires' disease caused by Legionella longbeachae and Legionella pneumophila: comparison of clinical features, host-related risk factors, and outcomes. Clin Microbiol Infect 2010; 16:1405.
  54. Den Boer JW, Nijhof J, Friesema I. Risk factors for sporadic community-acquired Legionnaires' disease. A 3-year national case-control study. Public Health 2006; 120:566.
  55. Straus WL, Plouffe JF, File TM Jr, et al. Risk factors for domestic acquisition of legionnaires disease. Ohio legionnaires Disease Group. Arch Intern Med 1996; 156:1685.
  56. Greenberg D, Chiou CC, Famigilleti R, et al. Problem pathogens: paediatric legionellosis--implications for improved diagnosis. Lancet Infect Dis 2006; 6:529.
  57. Lanternier F, Tubach F, Ravaud P, et al. Incidence and risk factors of Legionella pneumophila pneumonia during anti-tumor necrosis factor therapy: a prospective French study. Chest 2013; 144:990.
  58. Tubach F, Ravaud P, Salmon-Céron D, et al. Emergence of Legionella pneumophila pneumonia in patients receiving tumor necrosis factor-alpha antagonists. Clin Infect Dis 2006; 43:e95.
  59. Sivagnanam S, Podczervinski S, Butler-Wu SM, et al. Legionnaires' disease in transplant recipients: A 15-year retrospective study in a tertiary referral center. Transpl Infect Dis 2017; 19.
  60. Fernández-Sabé N, Rosón B, Carratalà J, et al. Clinical diagnosis of Legionella pneumonia revisited: evaluation of the Community-Based Pneumonia Incidence Study Group scoring system. Clin Infect Dis 2003; 37:483.
  61. Tobin JO, Beare J, Dunnill MS, et al. Legionnaires' disease in a transplant unit: isolation of the causative agent from shower baths. Lancet 1980; 2:118.
  62. Euser SM, Pelgrim M, den Boer JW. Legionnaires' disease and Pontiac fever after using a private outdoor whirlpool spa. Scand J Infect Dis 2010; 42:910.
  63. Ahmed M, Mustfa N. Hot tub Legionella pneumonia outbreak. Eur Respir J 2014; 44:1379.
  64. Smith SS, Ritger K, Samala U, et al. Legionellosis Outbreak Associated With a Hotel Fountain. Open Forum Infect Dis 2015; 2:ofv164.
  65. Phin N, Cresswell T, Parry-Ford F, Incident Control Team. Case of Legionnaires disease in a neonate following a home birth in a heated birthing pool, England, June 2014. Euro Surveill 2014; 19.
  66. Collins SL, Afshar B, Walker JT, et al. Heated birthing pools as a source of Legionnaires' disease. Epidemiol Infect 2016; 144:796.
  67. Quinn C, Demirjian A, Watkins LF, et al. Legionnaires' Disease Outbreak at a Long-Term Care Facility Caused by a Cooling Tower Using an Automated Disinfection System--Ohio, 2013. J Environ Health 2015; 78:8.
  68. Maisa A, Brockmann A, Renken F, et al. Epidemiological investigation and case-control study: a Legionnaires' disease outbreak associated with cooling towers in Warstein, Germany, August-September 2013. Euro Surveill 2015; 20.
  69. Simmons G, Jury S, Thornley C, et al. A Legionnaires' disease outbreak: a water blaster and roof-collected rainwater systems. Water Res 2008; 42:1449.
  70. Loenenbach AD, Beulens C, Euser SM, et al. Two Community Clusters of Legionnaires' Disease Directly Linked to a Biologic Wastewater Treatment Plant, the Netherlands. Emerg Infect Dis 2018; 24:1914.
  71. Cassell K, Gacek P, Warren JL, et al. Association Between Sporadic Legionellosis and River Systems in Connecticut. J Infect Dis 2018; 217:179.
  72. O'Connor BA, Carman J, Eckert K, et al. Does using potting mix make you sick? Results from a Legionella longbeachae case-control study in South Australia. Epidemiol Infect 2007; 135:34.
  73. Addiss DG, Davis JP, LaVenture M, et al. Community-acquired Legionnaires' disease associated with a cooling tower: evidence for longer-distance transport of Legionella pneumophila. Am J Epidemiol 1989; 130:557.
  74. Fraser DW. Legionellosis: evidence of airborne transmission. Ann N Y Acad Sci 1980; 353:61.
  75. Johnson JT, Yu VL, Best MG, et al. Nosocomial legionellosis in surgical patients with head-and-neck cancer: implications for epidemiological reservoir and mode of transmission. Lancet 1985; 2:298.
  76. Cianciotto NP, Eisenstein BI, Mody CH, Engleberg NC. A mutation in the mip gene results in an attenuation of Legionella pneumophila virulence. J Infect Dis 1990; 162:121.
  77. Hoffman PS, Ripley M, Weeratna R. Cloning and nucleotide sequence of a gene (ompS) encoding the major outer membrane protein of Legionella pneumophila. J Bacteriol 1992; 174:914.
  78. Payne NR, Horwitz MA. Phagocytosis of Legionella pneumophila is mediated by human monocyte complement receptors. J Exp Med 1987; 166:1377.
  79. Stone BJ, Abu Kwaik Y. Expression of multiple pili by Legionella pneumophila: identification and characterization of a type IV pilin gene and its role in adherence to mammalian and protozoan cells. Infect Immun 1998; 66:1768.
  80. Cianciotto NP, Stamos JK, Kamp DW. Infectivity of Legionella pneumophila mip mutant for alveolar epithelial cells. Curr Microbiol 1995; 30:247.
  81. Mody CH, Paine R 3rd, Shahrabadi MS, et al. Legionella pneumophila replicates within rat alveolar epithelial cells. J Infect Dis 1993; 167:1138.
  82. Burstein D, Amaro F, Zusman T, et al. Genomic analysis of 38 Legionella species identifies large and diverse effector repertoires. Nat Genet 2016; 48:167.
  83. Comas I. Legionella effectors reflect strength in diversity. Nat Genet 2016; 48:115.
  84. Joshi AD, Sturgill-Koszycki S, Swanson MS. Evidence that Dot-dependent and -independent factors isolate the Legionella pneumophila phagosome from the endocytic network in mouse macrophages. Cell Microbiol 2001; 3:99.
  85. Kagan JC, Roy CR. Legionella phagosomes intercept vesicular traffic from endoplasmic reticulum exit sites. Nat Cell Biol 2002; 4:945.
  86. Shin S, Roy CR. Host cell processes that influence the intracellular survival of Legionella pneumophila. Cell Microbiol 2008; 10:1209.
  87. Hammer BK, Tateda ES, Swanson MS. A two-component regulator induces the transmission phenotype of stationary-phase Legionella pneumophila. Mol Microbiol 2002; 44:107.
  88. Gao LY, Abu Kwaik Y. Apoptosis in macrophages and alveolar epithelial cells during early stages of infection by Legionella pneumophila and its role in cytopathogenicity. Infect Immun 1999; 67:862.
  89. Garduño RA, Garduño E, Hoffman PS. Surface-associated hsp60 chaperonin of Legionella pneumophila mediates invasion in a HeLa cell model. Infect Immun 1998; 66:4602.
  90. Robey M, O'Connell W, Cianciotto NP. Identification of Legionella pneumophila rcp, a pagP-like gene that confers resistance to cationic antimicrobial peptides and promotes intracellular infection. Infect Immun 2001; 69:4276.
  91. De Buck E, Anné J, Lammertyn E. The role of protein secretion systems in the virulence of the intracellular pathogen Legionella pneumophila. Microbiology (Reading) 2007; 153:3948.
  92. Cazalet C, Rusniok C, Brüggemann H, et al. Evidence in the Legionella pneumophila genome for exploitation of host cell functions and high genome plasticity. Nat Genet 2004; 36:1165.
  93. DebRoy S, Dao J, Söderberg M, et al. Legionella pneumophila type II secretome reveals unique exoproteins and a chitinase that promotes bacterial persistence in the lung. Proc Natl Acad Sci U S A 2006; 103:19146.
  94. Galka F, Wai SN, Kusch H, et al. Proteomic characterization of the whole secretome of Legionella pneumophila and functional analysis of outer membrane vesicles. Infect Immun 2008; 76:1825.
  95. Rossier O, Dao J, Cianciotto NP. The type II secretion system of Legionella pneumophila elaborates two aminopeptidases, as well as a metalloprotease that contributes to differential infection among protozoan hosts. Appl Environ Microbiol 2008; 74:753.
  96. Söderberg MA, Cianciotto NP. A Legionella pneumophila peptidyl-prolyl cis-trans isomerase present in culture supernatants is necessary for optimal growth at low temperatures. Appl Environ Microbiol 2008; 74:1634.
  97. Asare R, Santic M, Gobin I, et al. Genetic susceptibility and caspase activation in mouse and human macrophages are distinct for Legionella longbeachae and L. pneumophila. Infect Immun 2007; 75:1933.
  98. Gerhardt H, Walz MJ, Faigle M, et al. Localization of Legionella bacteria within ribosome-studded phagosomes is not restricted to Legionella pneumophila. FEMS Microbiol Lett 2000; 192:145.
  99. Kozak NA, Buss M, Lucas CE, et al. Virulence factors encoded by Legionella longbeachae identified on the basis of the genome sequence analysis of clinical isolate D-4968. J Bacteriol 2010; 192:1030.
  100. Joshi AD, Swanson MS. Comparative analysis of Legionella pneumophila and Legionella micdadei virulence traits. Infect Immun 1999; 67:4134.
  101. Alli OAT, Zink S, von Lackum NK, Abu-Kwaik Y. Comparative assessment of virulence traits in Legionella spp. Microbiology (Reading) 2003; 149:631.
  102. Maruta K, Miyamoto H, Hamada T, et al. Entry and intracellular growth of Legionella dumoffii in alveolar epithelial cells. Am J Respir Crit Care Med 1998; 157:1967.
  103. Weinbaum DL, Benner RR, Dowling JN, et al. Interaction of Legionella micdadei with human monocytes. Infect Immun 1984; 46:68.
  104. Slow S, Anderson T, Miller J, et al. Complete Genome Sequence of a Legionella longbeachae Serogroup 1 Strain Isolated from a Patient with Legionnaires' Disease. Genome Announc 2017; 5.
  105. Massis LM, Assis-Marques MA, Castanheira FV, et al. Legionella longbeachae Is Immunologically Silent and Highly Virulent In Vivo. J Infect Dis 2017; 215:440.
  106. Archer KA, Ader F, Kobayashi KS, et al. Cooperation between multiple microbial pattern recognition systems is important for host protection against the intracellular pathogen Legionella pneumophila. Infect Immun 2010; 78:2477.
  107. Mascarenhas DP, Zamboni DS. Inflammasome biology taught by Legionella pneumophila. J Leukoc Biol 2017; 101:841.
  108. Chiu YH, Macmillan JB, Chen ZJ. RNA polymerase III detects cytosolic DNA and induces type I interferons through the RIG-I pathway. Cell 2009; 138:576.
  109. Monroe KM, McWhirter SM, Vance RE. Identification of host cytosolic sensors and bacterial factors regulating the type I interferon response to Legionella pneumophila. PLoS Pathog 2009; 5:e1000665.
  110. Zhao Y, Yang J, Shi J, et al. The NLRC4 inflammasome receptors for bacterial flagellin and type III secretion apparatus. Nature 2011; 477:596.
  111. Deng JC, Tateda K, Zeng X, Standiford TJ. Transient transgenic expression of gamma interferon promotes Legionella pneumophila clearance in immunocompetent hosts. Infect Immun 2001; 69:6382.
Topic 7029 Version 26.0

References

آیا می خواهید مدیلیب را به صفحه اصلی خود اضافه کنید؟